Cargando…
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
Fibrosis is characterized by excessive deposition of the extracellular matrix and develops because of fibroblast differentiation during the process of inflammation. Various cytokines stimulate resident fibroblasts, which differentiate into myofibroblasts. Myofibroblasts actively synthesize an excess...
Autores principales: | Yoon, Somy, Kang, Gaeun, Eom, Gwang Hyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471162/ https://www.ncbi.nlm.nih.gov/pubmed/30884785 http://dx.doi.org/10.3390/ijms20061329 |
Ejemplares similares
-
Nitrosative Stress and Human Disease: Therapeutic Potential of Denitrosylation
por: Yoon, Somy, et al.
Publicado: (2021) -
HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016) -
Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease
por: Kim, Sung Hoon, et al.
Publicado: (2021) -
Heart failure with preserved ejection fraction: present status and future directions
por: Yoon, Somy, et al.
Publicado: (2019) -
Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation
por: Yoon, Somy, et al.
Publicado: (2020)